Josh Bilenker

Josh Bilenker

Director/Board Member chez SANA BIOTECHNOLOGY, INC.

Fortune : 200 800 $ au 29/02/2024

52 ans
Health Technology
Commercial Services
Consumer Services

Profil

Founder of Loxo Oncology, Inc. and Treeline Biosciences, Inc., Joshua H.
Bilenker
occupies the position of Chief Executive Officer & Director at Treeline Biosciences, Inc. He is also on the board of Sana Biotechnology, Inc. In the past Dr. Bilenker occupied the position of Head-Loxo Oncology Research at Eli Lilly & Co. and President, Chief Executive Officer & Director at Loxo Oncology, Inc. (a subsidiary of Eli Lilly & Co.), Medical Officer at US Food & Drug Administration, Board Observer at Aragon Pharmaceuticals, Inc. and Operating Partner at Aisling Capital LLC.
Dr. Bilenker received an undergraduate degree from Princeton University and a doctorate from The Johns Hopkins University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
03/04/2023 20 000 ( 0,01% ) 200 800 $ 29/02/2024
12/04/2023 0 ( -.--% ) - $ 29/02/2024

Postes actifs de Josh Bilenker

SociétésPosteDébut
SANA BIOTECHNOLOGY, INC. Director/Board Member 08/01/2021
Founder -
Tous les postes actifs de Josh Bilenker

Anciens postes connus de Josh Bilenker

SociétésPosteFin
GOSSAMER BIO, INC. Director/Board Member 08/06/2023
ELI LILLY AND COMPANY Corporate Officer/Principal 01/01/2021
Private Equity Investor 01/12/2019
LOXO ONCOLOGY INC Chief Executive Officer 01/02/2019
VIEWRAY, INC. Director/Board Member 01/06/2017
Voir l'expérience en détail de Josh Bilenker

Formation de Josh Bilenker

Princeton University Undergraduate Degree
The Johns Hopkins University School of Medicine Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Josh Bilenker

Relations

100 +

Relations au 1er degré

18

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées6
ELI LILLY AND COMPANY

Health Technology

LENSAR, INC.

Health Technology

VIEWRAY, INC.

Health Technology

T2 BIOSYSTEMS, INC.

Health Technology

GOSSAMER BIO, INC.

Health Technology

SANA BIOTECHNOLOGY, INC.

Health Technology

Entreprise privées10

Commercial Services

Finance

Health Technology

Government

Commercial Services

Health Technology

National Comprehensive Cancer Network Foundation

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Josh Bilenker